Clinical Trial: Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07911124) titled 'Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease' on Oct. 26.

Brief Summary: The goal of this clinical trial is to learn if treatment with ticagrelor tablets can decrease inflammation in patients with Chronic Kidney Disease (CKD). Inflammation is thought to contribute to the risk of heart disease which is the leading cause of death in patients with CKD. Decreasing inflammation may decrease the risk of heart disease.

The main questions it aims to answer are:

* Why are patients with CKD at increased risk for heart disease and how to reduce that risk in the future.

* If there could be new tr...